[Anti-NMDA-receptor encephalitis].
BACKGROUND In 2007 a clinical disease caused by autoantibodies directed against the N-methyl-D-aspartate (NMDA) receptor was described for the first time. Anti-NMDA-receptor encephalitis is a subacute, autoimmune neurological disorder with psychiatric manifestations. The disease is a form of limbic encephalitis and is often paraneoplastic. The condition is also treatable. In this review article we examine the development of the disease, clinical practice, diagnostics and treatment.MATERIAL AND METHOD The article is based on references retrieved from searches in PubMed, and a discretionary selection of articles from the authors' own literature archive.RESULTS The disease most frequently affects young women. It may initially be perceived as a psychiatric condition, as it usually presents in the form of delusions, hallucinations or mania. The diagnosis should be suspected in patients who later develop neurological symptoms such as various movement disorders, epileptic seizures and autonomic instability. Examination of serum or cerebrospinal fluid for NMDA receptor antibodies should be included in the assessment of patients with suspected encephalitis. MRI, EEG and assessment for tumours are important tools in diagnosing the condition and any underlying malignancy.INTERPRETATION If treatment is initiated early, the prognosis is good. Altogether 75 % of patients will fully recover or experience significant improvement. Apart from surgical resection of a possible tumour, the treatment consists of immunotherapy. Because of good possibilities for treatment, it is important that clinicians, particularly those in acute psychiatry, are aware of and alert to this condition.
NORMENT - Norsk senter for forskning på mentale lidelser K.G. Jebsen - senter for psykoseforskning Institutt for klinisk medisin Universitetet i Oslo og.
Kristine
K
Engen
NORMENT - Norsk senter for forskning på mentale lidelser K.G. Jebsen - senter for psykoseforskning Institutt for klinisk medisin Universitetet i Oslo og Avdeling for psykiatrisk forskning Diakonhjemmet Sykehus.
Ingrid
I
Agartz
D000328:Adult; D060426:Anti-N-Methyl-D-Aspartate Receptor Encephalitis / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D001323:Autoantibodies / Q000378:metabolism; D005260:Female; D006801:Humans; D011379:Prognosis; D011618:Psychotic Disorders / Q000209:etiology; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000378:metabolism
D001323:Autoantibodies; D016194:Receptors, N-Methyl-D-Aspartate